Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 11 of 58, showing 10 Applications out of 576 total, starting on record 101, ending on 110

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

101.

ECCT/15/09/01   NuvaRing Study
    Effects of contraceptive ring on vaginal microbiota, HIV shedding and local immunity   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
Thika Partners Study Clinic (Partners in Health Research and Development) affiliated to the University of Washington International Clinical Research Center (ICRC), and KEMRI
 
16-02-2016 View

102.

ECCT/15/10/01   VRC01 Monoclonal HIV Antibodies Study
    Safety  and  Virologic Effect  Of  A  Human   Monoclonal   Antibody,   VRC-HIVmAb060-00-Ab  (VRCOl),   With Broad  HIV-1  Neutralizing Activity, Administered Intravenously to Adults  During Early Acute HIV Infection.   
Principal Investigator(s)
1. Josphat K Kosgei
Site(s) in Kenya
KEMRI Walter Reed Project Kericho
 
20-03-2016 View

103.

ECCT/15/10/02  
    A non-randomized, open label, single dose, pharmacokinetics, safety and tolerability study of Captopril 50mgs in healthy Kenyan Adults.   
Principal Investigator(s)
1. Bernhards Ragama Ogutu
Site(s) in Kenya
KEMRI centre for clinical Research
 
02-12-2015 View

104.

ECCT/15/10/03   Safer Conception Intervention for Partners (SCIP)
    Pilot of an mHealth-enhanced, safer conception intervention to reduce HIV-1 risk among Kenyan HIV-1 serodiscordant couples   Safer Conception Intervention for Partners (SCIP)   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
Thika Partners Study Clinic (Partners in Health Research and Development) affiliated to the University of Washington International Clinical Research Center (ICRC), and KEMRI
 
11-01-2016 View

105.

ECCT/15/10/04   AZM
    Azithromycin (AZM) to prevent post-discharge    morbidity and mortality in Kenyan children   
Principal Investigator(s)
1. Judd Walson Walson
Site(s) in Kenya
1. Homa Bay County referral Hospital (Homa Bay county)
2. Kisii Teaching and referral Hospital (Kisii county)
 
09-02-2016 View

106.

ECCT/15/11/01   A5264
    A Randomized Evaluation of Antiretroviral Therapy Alone or with Delayed Chemotherapy   versus Antiretroviral Therapy with Immediate Adjunctive Chemotherapy for Treatment of   Limited Stage AIDS-KS in Resource-Limited Settings (REACT-KS)   
Principal Investigator(s)
1. Dr. Victor Otieno Mudhune
Site(s) in Kenya
1. KEMRI CDC (Kisumu county)
 
05-05-2016 View

107.

ECCT/15/11/02  
    EFFECT OF LARYNGEAL MASK AIRWAY MANOMETRY ON POST OPERATIVE SORE THROAT IN SPONTANEOUSLY BREATHING ADULT PATIENTS PRESENTING FOR SURGERY AT AGA KHAN UNIVERSITY HOSPITAL, NAIROBI.   
Principal Investigator(s)
1. Prof Vitalis Mungayi
2. Dr Edna Kemunto Gisore
3. Dr David Njoroge Waruingi
Site(s) in Kenya
Aga Khan University Hospital Nairobi
 
02-12-2015 View

108.

ECCT/15/11/04   VAC040
    A Phase 1/2, Randomized, Placebo-controlled, Double-blind Study to Assess the Safety, Tolerability, and Immunogenicity of Stretococcus pneumoniae Whole Cell Vaccine, Inactivated and Adsorbed to Aluminum Hydroxide (PATH-wSP) in Healthy Kenya Young Adults (18 - 40years) and Toddlers (12 - 19months)   
Principal Investigator(s)
1. John Anthony Gerard Scott
Site(s) in Kenya
KEMRI-Wellcome Trust Research Program
 
09-02-2016 View

109.

ECCT/15/11/05   FALCI Study
    A Randomized, Double-blind, Phase IIb Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine (FQ) with Artefenomel (OZ439) in Adults and Children with Uncomplicated Plasmodium falciparum Malaria.   
Principal Investigator(s)
1. Grace Kiringa Kaguthi
Site(s) in Kenya
1. KEMRI Center for Respiratory Diseases Research (Siaya county)
2. KEMRI Walter Reed Kombewa (Kisumu county)
3. KEMRI Kisumu (Kisumu county)
 
01-02-2016 View

110.

ECCT/15/12/01   A Randomized Controlled Trial of ASPIRIN in Nulliparous Pregnant Women(ASPIRIN STUDY)
        Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN): A Prospective randomized, placebo-controlled, double-blinded clinical trial in western Kenya.   
Principal Investigator(s)
1. Prof Fabian Esamai Omoding Esamai
Site(s) in Kenya
1. Amukura, Lukolis,Nasewa,Matayos,Khunyangu, Bumala B (Busia county)
2. Sirisia, Chwele, Bokoli (Bung\'oma county)
3. Makunga, Mumias (Kakamega county)
 
16-02-2016 View